CRISPR Therapeutics
CRISPR Therapeutics
crisprtx.com

Locations

United States · Massachusetts, USA · Switzerland · Cambridge, MA, USA · Basel, Switzerland · North America · Cambridge, MA, USA · United Kingdom · London, UK

industry

Biotechnology · DeepTech · Health

Size

201-1000 employees

Stage

Other

founded in

2013

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeutics’ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.

Something looks off?
Open jobs at CRISPR Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.